We are live on ! Find out more
Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $110B
1-Year Est. Return 4.8%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Fund
S&P 500
This Quarter Est. Return
+0.02%
1 Year Est. Return
+4.8%
3 Year Est. Return
+123.53%
5 Year Est. Return
+125.55%
10 Year Est. Return
+1,754.37%
AUM
$182B
AUM Growth
-$8.9B
Cap. Flow
-$1.05B
Cap. Flow %
-0.58%
Top 10 Hldgs %
39.59%
Holding
518
New
26
Increased
181
Reduced
122
Closed
19

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$3.07B
2
YMM icon
Full Truck Alliance
YMM
+$1.57B
3
RMD icon
ResMed
RMD
+$715M
4
NVDA icon
NVIDIA
NVDA
+$647M
5
BABA icon
Alibaba
BABA
+$597M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 26.6%
2 Healthcare 23.23%
3 Technology 20.07%
4 Communication Services 12.81%
5 Financials 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASXC
476
DELISTED
Asensus Surgical, Inc.
ASXC
$6K ﹤0.01%
5,338
ATRI
477
DELISTED
Atrion Corp
ATRI
$6K ﹤0.01%
9
TWOU
478
DELISTED
2U Inc
TWOU
$6K ﹤0.01%
11
CVGW
479
DELISTED
Calavo Growers
CVGW
$5K ﹤0.01%
113
GAN
480
DELISTED
GAN Ltd
GAN
$5K ﹤0.01%
572
INGN icon
481
Inogen
INGN
$164M
$5K ﹤0.01%
141
SEER icon
482
Seer Inc
SEER
$120M
$5K ﹤0.01%
223
DMTK
483
DELISTED
DermTech, Inc. Common Stock
DMTK
$5K ﹤0.01%
286
VRAY
484
DELISTED
ViewRay, Inc.
VRAY
$5K ﹤0.01%
911
AGX icon
485
Argan
AGX
$8.37B
$4K ﹤0.01%
103
AI icon
486
C3.ai
AI
$1.59B
$4K ﹤0.01%
117
ALKS icon
487
Alkermes
ALKS
$8.25B
$4K ﹤0.01%
192
PAGS icon
488
PagSeguro Digital
PAGS
$2.55B
$4K ﹤0.01%
+148
New +$4.82K
ZYXI
489
DELISTED
Zynex
ZYXI
$4K ﹤0.01%
481
HCSG icon
490
Healthcare Services Group
HCSG
$1.53B
$3K ﹤0.01%
157
HRTX icon
491
Heron Therapeutics
HRTX
$92.9M
$3K ﹤0.01%
308
AMRX icon
492
Amneal Pharmaceuticals
AMRX
$5.79B
$2K ﹤0.01%
452
AXDX
493
DELISTED
Accelerate Diagnostics
AXDX
$2K ﹤0.01%
42
QTTB icon
494
Q32 Bio
QTTB
$464M
$2K ﹤0.01%
27
ICPT
495
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2K ﹤0.01%
101
CCSI icon
496
Consensus Cloud Solutions
CCSI
$647M
$1K ﹤0.01%
+24
New +$1.46K
AFIB
497
DELISTED
Acutus Medical Inc
AFIB
$1K ﹤0.01%
424
EAR
498
DELISTED
Eargo, Inc. Common Stock
EAR
$1K ﹤0.01%
13
AEP icon
499
American Electric Power
AEP
$68.4B
-619,364
Closed -$50.3M
ATHM icon
500
Autohome
ATHM
$2.62B
-2,979,984
Closed -$140M

Similar funds

Baillie Gifford & Co's Q4 2021 Portfolio in Review

As of Q4 2021, Baillie Gifford & Co held 518 positions worth $182B, down 4.7% from $191B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Baillie Gifford & Co's Q4 2021 filing shows 26 new, 181 increased, 122 reduced and 19 closed positions. Its largest new stake was Charles Schwab: 7,506,268 shares worth $631M. The largest sale was Tesla, an estimated $3.07B.

By sector, the portfolio is most concentrated in Consumer Discretionary at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Technology.

  • Baillie Gifford & Co's largest Q4 2021 buy was Charles Schwab: 7,506,268 shares worth $631M.
  • Baillie Gifford & Co added most to Moderna in Q4 2021, an estimated $1.04B increase.
  • Baillie Gifford & Co's biggest Q4 2021 reduction was Tesla, cutting an estimated $3.07B.
  • Baillie Gifford & Co fully exited Autohome in Q4 2021, selling an estimated $140M.
  • Baillie Gifford & Co's ten largest holdings make up 40% of its $182B portfolio in Q4 2021.
  • Baillie Gifford & Co opened 26 new positions and closed 19 in Q4 2021.
  • Baillie Gifford & Co's portfolio value fell 4.7% quarter-over-quarter to $182B.

Based on Baillie Gifford & Co's 13F filing for Q4 2021, filed 20 Jan 2022.